Generics 9

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dimetindene maleate manufacturers

9 products found

Filters

9 products found

dimetindene maleate

Cutaneous gel 1%,

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo , Taiwan
Manufacturer #11724

Manufacturer usually replies in 5 days

dimetindene maleate

Solution for injection 4 mg/4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #298

Manufacturer usually replies in 5 days

dimetindene maleate

Cutaneous gel 0.1% (WEU dossier)

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1250

Manufacturer usually replies in 7 days

dimetindene maleate

Cutaneous gel 1 mg/ml - 30 g, 50 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years. Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders. The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture. Regularity team prepares EU CTD format document.

Manufacturer usually replies in 16 days

dimetindene maleate

Oral solution 1 mg/ml - 20 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2024
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years. Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders. The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture. Regularity team prepares EU CTD format document.

Manufacturer usually replies in 16 days

dimetindene maleate

Cutaneous gel 0.1 %

Dossier type
EU CTD
Dossier status
Under development
Country of origin
North Macedonia
GMP approvals
EU GMP
Manufacturer #2692
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, and North America with 10+ branches for 80+ years. Key production lines are Rx and OTC drugs, medical devices, food supplements, chemical products, cosmetics, and herbal meds with EU GMP standards. The main dosage forms are solid and liquid oral and topical preparations. The company possesses its own R&D institute.

Manufacturer usually replies in 9 days

dimetindene maleate

Oral drops 1 mg/1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
WHO
Unavailable markets
Iraq
Manufacturer #16655
It was founded in the 1990s with a mission to improve people’s health by developing safe and high-quality branded first generic medicines at affordable prices. This was at a time when several local and international pharmaceutical products were present in the local market but lacked alternative non-branded products, especially in the Central Nervous System (CNS) medicines. More than 20 years later, they remain committed to improving people’s health, enhancing medicines, and extending their reach to the communities in which they operate.

Manufacturer usually replies in 3 days

dimetindene maleate + phenylephrine

Nasal spray 0.025% + 0.25%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan
Registered in
Jordan
Manufacturer #6980
It was established in the late 1980s. It is one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of ophthalmology, ear, nose & throat, respiratory, and dermatology. After many years of success, the company is still focused on its differentiator and is proud to be one of the leaders in the MENA region having expanded into more than 5 production lines producing 140+ registered products, and exporting to 30+ markets globally.

Manufacturer usually replies in 6 days

dimetindene maleate

Oral drops 0.1%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan
Registered in
Jordan
Manufacturer #6980
It was established in the late 1980s. It is one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of ophthalmology, ear, nose & throat, respiratory, and dermatology. After many years of success, the company is still focused on its differentiator and is proud to be one of the leaders in the MENA region having expanded into more than 5 production lines producing 140+ registered products, and exporting to 30+ markets globally.

Manufacturer usually replies in 6 days

DIMETHINDENE MALEATE

Dimetindene is a potent antipruritic antihistamine that is a selective H1 antagonist, used in the symptomatic treatment of insect bites and sunburns. Its primary form Dimetindene is used for curing allergic reactions like urticaria, allergies of the upper respiratory tract like perennial rhinitis and hay fever, in curing food, and drug allergies, some pruritus, insect bites. It is also used in the treatment of pruritus in eruptive skin diseases like chickenpox, as an adjuvant in the treatment of eczema and other allergies of pruriginous dermatoses origin. Its outstanding characteristic is the small size of its effective doses and the rapid onset of action, which takes effect within 20 to 60 minutes and gives relief for several hours. Dimetindene Maleate is sold under the trade name Forestal and Fenistil among others. Novartis owns the current right for Dimetindene Maleate. However, it first came into use in 1960 after it was patented in the late 1950s.

Dosage and administrations

Dimetindene Maleate is sold as gel, emulsion, drops as well as a syrup that particularly for use in children. One teaspoonful syrup contains 5ml of the drug that is equal to the 0.5mg Coated tablets. The standard recommended dosage for adults is 3-6 tablets. The standard dose varies by age, where if taking the Drops, the dose for Infants up to 1 year is 10-30 drops, for Infants of 1 to 3 years age the dose is 30-45 drops, in treating Children over 3 years, the dose recommended is 45-60 drops and for Adults, the dose is 60-120 drops. If using the Syrup, the standard dose for infants up to 1 year is 1-3 teaspoons and for Infants of 1 to 3 years, the dose is 3-4 teaspoons. For treating children over 3 years the dose is 4-6 teaspoons and for Adults, the dose is 6-12 teaspoons.

The cost of Dimetindene Maleate

In India, the consumers buy 250 Dimetindene Maleate Tablets of 1 Mg for as low as USD4. In Europe, the oral drops of 20 ml cost around EUR 6.61, and the 0.1% concentration gel of 20ml cost around 9 pounds in the UK.

How does Dimetindene Maleate Work?

Dimethindene is a strong and selective histamine H1 antagonist. Its actions bind it to the histamine H1 receptor competing with it. The result of this blocking is the action of endogenous histamine. This whole process eventually leads to temporary relief from the negative symptoms brought on by histamine generation in the body during an allergic reaction.

Finding DIMETHINDENE MALEATE Manufacturers and Suppliers:

The process of finding trusted DIMETHINDENE MALEATE manufacturers and DIMETHINDENE MALEATE suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use an online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of DIMETHINDENE MALEATE. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.